scispace - formally typeset
S

Shoji Ohno

Researcher at Jichi Medical University

Publications -  59
Citations -  6052

Shoji Ohno is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Bronchoalveolar lavage & Idiopathic interstitial pneumonia. The author has an hindex of 17, co-authored 59 publications receiving 5580 citations. Previous affiliations of Shoji Ohno include International University of Health and Welfare.

Papers
More filters
Journal ArticleDOI

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

TL;DR: It is shown that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-associated protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.
Journal ArticleDOI

Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation.

TL;DR: The results suggest that soluble human ST2 protein in sera may be related to Th2-mediated allergic inflammation inducing acute exacerbation in patients with atopic asthma.
Journal ArticleDOI

Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries.

TL;DR: It is suggested that alveolar epithelial cells can incorporate exogenous particles, which are then transferred from the alveoli to intravascular spaces by transcytosis.
Journal ArticleDOI

Expression of ST2 in helper T lymphocytes of malignant pleural effusions.

TL;DR: The results suggest that CD4+ T cells in CA shift to Th2, which can produce soluble ST2 protein, resulting in increased concentrations of p-ST2 in malignant pleural effusion.
Journal ArticleDOI

Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release

TL;DR: Results suggest that macrolides inhibit epithelial cell-mediated neutrophil survival by modulating GM-CSF release, which may, at least in part, explain the effectiveness of this family of drugs on DPB.